AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private placement
by Hans Christian Leren | Apr 29, 2021
29.4.2021 16:59:54 CEST | Aqua Bio Technology ASA | Inside information
AQUA BIO TECHNOLOGY: board issuance of offer shares in completed private
placement
Reference is made to the stock exchange announcement by Aqua Bio Technology (the
"Company or ABT") on 15 April 2021 regarding the completion of a private
placement raising gross proceeds of up to approximately NOK 15 million (the
"Private Placement") at a fixed subscription price of NOK 11.45 per new share
(the "Offer Shares") towards Akvakulturpartner AS, an investment company which
focuses on attractive and innovate aquaculture opportunities, and certain other
external investors.
The interest for the Private Placement was high and the Offer Shares were
significantly oversubscribed the same afternoon. The Company values the support
from Akvakulturpartner AS, the other investors who subscribed for the Offer
Shares and the continued support from its shareholders in the Company's ambition
to grow by developing its products.
-The interest in the Private Placement demonstrated that we have confidence in
the market. We are experiencing exciting times at ABT, both in product
development and commercialization of our products, says CEO Espen Kvale of ABT.
The Company's board of directors has today formally resolved to issue the Offer
Shares in the Private Placement pursuant to available board authorizations to
settle the share lending arrangement with shareholder Kjeveortoped Espen Dahls
AS. Such shares will be issued on a separate, non-tradable ISIN, awaiting
approval and publication of a listing prospectus.
For further information, please contact CEO Espen Kvale, telephone +47 9162
8092.
* * *
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. ABT's focus on commercialization and development of natural
ingredients and natural skin care products has been, and will continue to be, an
important part of the Company's strategy going forward.
Aqua Bio Technology is listed on the Euronext Expand market of the Oslo Stock
Exchange.
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act. The stock exchange announcement
was published by Håvard Lindstrøm, Head of Business Development, on 29 April
2021 at 17.00 CET.
DISCLOSURE REGULATION
This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.
CONTACTS
* Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
ABOUT AQUA BIO TECHNOLOGY ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/509/647/Download%20announcement%2
0as%20PDF.pdf
Recent Comments